Evinacumab Reduces Lipids, Cholesterol in Hypercholsterolemi

Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.

Related Keywords

Linkedin Muhammad Saqlain Mustafa , Robert Rosenson , Muhammad Saqlain Mustafa , Aga Khan University Hospital , Drug Administration , Regeneron Pharmaceuticals Inc , Cardiometabolic Disorders , Icahn School , Treating Hypercholesterolemia , Systematic Review , Randomized Controlled , Drug Evaluation ,